Fig. 82From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseMolecular docking of C93 with MAO-B (a, b) [12]Back to article page
